The Freebird Club

Within communities food businesses frequently experience food surpluses, as a consequence of the modern food system, while charities struggle to provide food for those who need it most. FoodCloud provides a simple way for food businesses to contribute to their communities in a meaningful and practical way and reduce their impact on the environment. By receiving surplus food, charities can reduce their food costs and redirect funding to programs assisting those who are disadvantaged, creating tangible and long lasting local benefits. In two years they've donated over 1.5m meals to charities from surplus food. They are working with over 150 retail stores in Ireland and the UK and over 350 charities. They have big ambitions to expand internationally.

MixRift is a gaming company that focuses on creating interactive and mixed-reality gaming experiences.

MoveAhead is a digital platform designed for children that offers personalized play experiences and feedback, catering to their play, involvement, and development. Specifically created for children, it features a motion tracking engine.

Kwayga is a specialist in creating a global business network that connects B2B companies, enabling them to share insights and expertise.

EMA Aesthetics Limited is established in Ireland and specialises in the fields of professional aesthetics and skincare technology. The company currently owns HydraCool and SRS brands. EMA Aesthetics is present in 39 countries worldwide and operates in Ireland, Belgium, UAE and Singapore. EMA is committed to sustainable growth, product development and skincare innovation globally.

Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC). NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes. Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.

TULU is the Usage Economy platform that elevates products and services brands to win today’s needs-driven consumers. We provide building tenants with on-demand access to hundreds of brand-name appliances, grocery staples, and micro-mobility and entertainment devices, in residential buildings, student housing, and offices. TULU’s IoT-based smart rental units are customized to provide the most necessary and useful items, while leveraging data to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. We are a global company with operations in 15 cities across the US and Europe, working with the largest landlords in the world, such as Greystar Real Estate Partners, Brookfield Asset Management, Invesco, RXR Realty and CA Ventures, and top brand manufacturers such as Bosch, Hoover, Kärcher and Unagi.

A world of parenting resources in one place, so you can get the exact help you need to be the parent you want to be.

CityLegends is a platform that brings together urban athletes and artists. It allows people to explore the urban world, connect with others, compete fiercely, and leave a lasting legacy. Our goal is to create a highly engaged community of urban athletes and artists and give them a platform to express their voices. LINES by CityLegends is an Urban Institute that supports policymakers, partners, and communities in the field of urban sports and culture. We create connections between partners, cities, governments, and alternative youth cultures through our digital urban platform, city dashboard, and urban creators. We are proud to have connected over 100,000 young citizens and reach millions of people every month. We also assist over 40 municipalities, brands, and governments in developing strategies to create active, social, and vibrant communities for young citizens. Our values include independence, being a forever community, supporting freedom, making voices heard, shaping cities, and most importantly, never being done.

Marleybones is a company that focuses on producing and selling dog food.

Midi Health offers virtual care for women, specializing in treating depression, gynecological cancer, and menstrual issues. The clinic provides personalized treatment plans created by clinicians skilled in women's midlife health. They utilize at-home testing, medications, supplements, and lifestyle coaching to help patients manage their conditions.

Sunrise is striving to provide uncomplicated solutions to the millions of individuals who are struggling with sleep disorders. Our innovative 3-gram sensor has been devised to diagnose sleep disorders utilizing the highest quality gold standard methodology. The revolutionary technology allows for the assessment of brain activity during the night, providing unprecedented clinical results. The findings from studies indicate that Sunrise is as precise as in-lab sleep studies, but at a significantly lower cost. Sleep disorders affect one-third of the population, with sleep apnea being the most common, impacting almost one billion individuals globally. This ailment can cause unintentional harm to the body over time and unfortunately, goes unnoticed in 80% of cases. The introduction of a less complex, less costly, and less time-consuming diagnostic system would greatly benefit patients, healthcare professionals, and insurance providers.